Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Rhodes Pharmaceuticals L.P. with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Shortage of an active ingredient
Shortage details
- Status
- Current
- Company
- Rhodes Pharmaceuticals L.P.
- Package NDC
- 42858-164-01
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)
- Initial Posting
- Jul 14, 2023
Reason
Shortage of an active ingredient